Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Extensive preclinical evaluation establishes potential of novel antitumor agent --CHS-828

April 22, 1999

Promising phase I/II data for 81C6 pave the way for phase III trials in brain tumor patients

April 22, 1999

Favorable efficacy and safety profile of CEP-701 in PDAC

April 22, 1999

PNU-159548 undergoes phase I trials; preclinical results presented at AACR meeting

April 22, 1999

Efficacy of IL-2 Gene Medicine is enhanced by combination with chemotherapeutic agent

April 22, 1999

GnRH pharmaccine reduces testosterone to castration levels

April 22, 1999

Small peptide from Angstrom highly active against human breast tumor xenografts

April 21, 1999

Sanofi and Lilly to jointly develop oxaliplatin in U.S.

April 21, 1999

SQ-885: a specific angiogenesis inhibitor and integrin antagonist

April 21, 1999

Immunomedics clones RNase and prepares RNase-containing anticancer fusion protein

April 21, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...